Bridging the Gap: Health Equity and Barriers in Patients Living With BP-I Disorder
Location: 205
Innovation Theater
Wednesday, Sep 6th
12:15 PM – 1:30 PM CT
Deplin® as Early Adjunctive Therapy in Major Depressive Disorder
Location: 202
Innovation Theater
Wednesday, Sep 6th
12:15 PM – 1:30 PM CT
Forging a New Path: Targeting Muscarinic Receptor Circuits in Schizophrenia
Location: 209
Innovation Theater
Thursday, Sep 7th
7:30 AM – 8:45 AM CT
LAI Antipsychotic Therapy for Adults With Schizophrenia
Location: 205
Innovation Theater
Thursday, Sep 7th
7:30 AM – 8:45 AM CT
Redefining the Treatment of Insomnia
Location: 202
Innovation Theater
Thursday, Sep 7th
12:00 PM – 1:15 PM CT
Addressing Unresolved Symptoms of Major Depressive Disorder (MDD)
Location: 209
Innovation Theater
Thursday, Sep 7th
12:00 PM – 1:15 PM CT
An Established Therapy for Treatment-resistant Depression (TRD) in Adults
Location: 104
Innovation Theater
Thursday, Sep 7th
12:00 PM – 1:15 PM CT
Beyond the Monoamine Hypothesis: a glutamatergic approach to treating major depressive disorder
Location: 202
Innovation Theater
Thursday, Sep 7th
12:00 PM – 1:15 PM CT
Beyond Trauma: Understanding the Neurobiology and Presentation of Posttraumatic Stress Disorder.
Location: 101
Innovation Theater
Thursday, Sep 7th
12:00 PM – 1:15 PM CT
The Science of TAAR1: A Potential New Target in Psychiatric Disorders
Location: 205
Innovation Theater
Thursday, Sep 7th
12:00 PM – 1:15 PM CT
Understanding TD from Impact to Treatment
Location: 207
Innovation Theater
Friday, Sep 8th
7:30 AM – 8:45 AM CT
Adjunctive Treatment for Major Depressive Disorder in Adults
Location: 205
Innovation Theater
Friday, Sep 8th
7:30 AM – 8:45 AM CT
Clinical Perspectives on Bipolar I and Bipolar II Depression, and a Treatment Option Approved For Both
Location: 202
Innovation Theater
Friday, Sep 8th
7:30 AM – 8:45 AM CT
Evolution of ADHD Prodrug Therapies
Location: 207
Innovation Theater
Friday, Sep 8th
12:00 PM – 1:15 PM CT
A Patient-Centered Approach to Postpartum Depression Care
Location: 209
Innovation Theater
Friday, Sep 8th
12:00 PM – 1:15 PM CT
Facing the Overlooked Symptoms of Schizophrenia: A Clinical Conversation About Cognitive and Negative Symptoms
Location: 207
Innovation Theater
Friday, Sep 8th
12:00 PM – 1:15 PM CT
Providers Discuss a Novel LAI Treatment Option for Schizophrenia or maintenance treatment for Bipolar I Disorder in Appropriate Adult Patients
Location: 202
Innovation Theater
Friday, Sep 8th
12:00 PM – 1:15 PM CT
The Impact of Tardive Dyskinesia: The Data and a Patient Story
Location: 205
Innovation Theater
Friday, Sep 8th
2:00 PM – 3:00 PM CT
The Rapid Mood Screener (RMS) in Routine Clinical Practice: Application and Impact in Differentiating Depressive Episodes
Location: Theater in Exhibit Hall
Innovation Theater
Saturday, Sep 9th
7:30 AM – 8:45 AM CT
An MDD Treatment Option: From Clinical Data to Patient Impact
Location: 205
Innovation Theater
Saturday, Sep 9th
7:30 AM – 8:45 AM CT
Prescribing Hope – The Impact of Long-Acting Injectables on the Unhoused Community
Location: 202
Innovation Theater
Saturday, Sep 9th
12:00 PM – 1:15 PM CT
Clinical Considerations for Psychiatrists on the Improvement of Wakefulness in Patients with Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea
Location: 207
Innovation Theater
Saturday, Sep 9th
12:00 PM – 1:15 PM CT
Discover the Difference With a New LAI for the Treatment of Schizophrenia
Location: 205
Innovation Theater
Saturday, Sep 9th
12:00 PM – 1:15 PM CT
Learn About an Oral Treatment Option for Adults With Schizophrenia or Bipolar I Disorder
Location: 209
Innovation Theater
Saturday, Sep 9th
12:00 PM – 1:15 PM CT
The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients with Major Depressive Disorder (MDD)
Location: 202
Innovation Theater
Saturday, Sep 9th
2:00 PM – 3:00 PM CT
Determining Clinician Factors for Implementing LAIs and Defeating Barriers (DECIDE): Results from a Survey of US-Practicing Psychiatric Clinicians
